This under-the-skin injection is the first FDA-approved drug for chronic weight management in obese or overweight adults since 2014
Food and Drug Administration granted approval for Wegovy (semaglutide) injection at a 2.4 mg dosage, administered once weekly
In the last decades, IGF-1 has been implicated in many physiological actions, among others: tissue growth and development, proliferative, lipid metabolism, pro-survival/anti-aging, anti-inflammatory, anabolic, and antioxidant with neuro- and hepatoprotective properties [105116]
doi: 10.1089/thy.2012.0548 81 LiuMSongJJiangYLiuYPengJLiangHet al
Once you stop injecting or taking the medication, your brain's hunger centers reactivate, and your baseline appetite hormones return to their original set point
Additionally, the FDA continued its regulatory action against the sale/distribution of unapproved opioid products